Ferritin as a Marker of Severity in Covid 19 Patients

Retrospective Study to assess Ferritin as a marker of severity in Covid 19 patients - Ferritin in Covid 19

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2021/10/037514

Enrollment

128

Registered

2021-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B338- Other specified viral diseases

Interventions

Control Intervention1: Retrospective study to assess Ferritin as a Marker of Severity in Covid 19 Patients : NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1)Lab confirmed COVID 19 by RT-PCR test 2)Patients admitted between APRIL 2020 to APRIL 2021 3) > 16 years of Age 4)Duration of Admission more than 7 days

Exclusion criteria

Exclusion criteria: 1)COVID -19 RT-PCR Negative 2) 3)Pregnancy 4)Duration of Admission Less than 7 days 5)Patients with prior Renal failure, chronic inflammatory disorders like (RA, Autoimmune disorders, Inflammatory bowel disease, Malignancy) 6)Patients with other infections either preexisting or diagnosed secondary infections after admission

Design outcomes

Primary

Measure	Time frame
correlation of serum ferritin levels with severity of COVID 19 illness (Severe versus Non-Severe Covid 19)Timepoint: APRIL 2020 to APRIL 2021	—

Secondary

Measure	Time frame
Correlation of admission serum ferritin levels with severity of COVID-19 illness to assess its utility as a prognostic marker.Timepoint: APRIL 2020 to APRIL 2021	—

Countries

India

Contacts

Public ContactDr ROHITH KUMAR

Dr TMA PAI Hospital

drshettyseema@yahoo.com9845856769

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026